Allan Dietz is an accomplished Scientist of Regenerative Medicine at Mayo Clinic, where contributions since October 1996 include serving as Director of the Immune, Progenitor, and Cell Therapy program (IMPACT) and Co-Director of the Human Cell Therapy Lab. In addition to roles at Mayo Clinic, Allan Dietz has been a Scientific Advisor at Mill Creek Life Sciences since 2012. Allan Dietz holds a Ph.D. in Genetics from Texas A&M University (1987-1991) and a Bachelor of Arts in Chemistry and Biology from the University of Northern Iowa (1982-1986).